Get the Stockscreener App
0.8556
5.89%
0.0476
After Hours:
.90
0.0444
+5.19%
Mdxhealth Sa stock is traded at $0.8556, with a volume of 10.43M.
It is up +5.89% in the last 24 hours and up +102.37% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
See More
Previous Close:
$0.808
Open:
$0.71365
24h Volume:
10.43M
Relative Volume:
1.75
Market Cap:
$43.95M
Revenue:
$110.97M
Net Income/Loss:
$-33.18M
P/E Ratio:
-1.3015
EPS:
-0.6574
Net Cash Flow:
$-11.80M
1W Performance:
+88.46%
1M Performance:
+102.37%
6M Performance:
-75.62%
1Y Performance:
-69.98%
1-Day Range:
$0.7099
$0.93
1-Week Range:
$0.4348
$1.13
52-Week Range:
$0.40
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.8556 | 41.50M | 110.97M | -33.18M | -11.80M | -0.6574 |
TMO
Thermo Fisher Scientific Inc
|
585.51 | 217.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.63 | 142.32B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
314.18 | 44.67B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
546.09 | 43.41B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.45 | 41.95B | 7.23B | 1.41B | 1.09B | 4.979 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | Craig Hallum | Buy |
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
MDxHealth (MDXH) investors reveal 19.5% and 12.1% stakes - Stock Titan
MDxHealth price target lowered to $3 from $5 at Lake Street - TipRanks
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA' - Sahm
Mdxhealth S.A. Earnings Call Shows Growth, Strain - TipRanks
MDXH Maintained by Lake Street -- Price Target Lowered to $3.00 - GuruFocus
Bleichroeder LP Discloses Investment at MDxHealth SA with 33.2% Stake - TradingView
MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside - TradingView
Bleichroeder (MDXH) reports 31.6M-share, 33.2% holding in MDxHealth - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
MDxHealth SA Stock 12‑Month Price Target Cut to $2.6, Implies 463% Upside - TradingView
MDxHealth S.A. Q2 2026 Earnings Call Summary - Yahoo Finance
MDxHealth (MDXH) Q2 2026 Earnings Call: Umsatz erholt sich, Prognose bestätigt - TradingKey
Conferencia de resultados del T2 de 2026 de MDxHealth (MDXH): los ingresos se recuperan, se mantienen las previsiones - TradingKey
MDxHealth (MDXH) Q2 2026 Earnings Call: Revenue Rebounds, Guidance Maintained - TradingKey
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record S - GuruFocus
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic ... - finance.yahoo.com
MDxHealth Q2 Results: Revenue up 16% YoY, Adjusted EBITDA turns negative - scanx.trade
MDXH Looks 79.0% Undervalued on GF Value™ but Faces Value Trap W - GuruFocus
Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026 - Investing.com
MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
MDxHealth SA reports results for the quarter ended June 30Earnings Summary - TradingView
MDxHealth Raises $20 Million in Direct Share Offering and Amends Articles After Capital Increase - TipRanks
MDxHealth Posts Q2 2026 Revenue Growth, Exits Resolve Business and Raises $20 Million - TipRanks
MDxHealth ADR earnings missed, revenue topped estimates - Investing.com
MDXHEALTH SA ($MDXH) Releases Q2 2026 Earnings - Quiver Quantitative
MDxHealth (MDXH) sells 44M shares, lifting total stock to 95.4M - Stock Titan
MDxHealth (NASDAQ: MDXH) lifts Q2 2026 revenue 16% but posts deeper loss - Stock Titan
Mdxhealth Sells 44M Shares for $20M Gross as Q2 Net Loss Hits $9.5M - Stock Titan
MDxHealth (MDXH) investor Laurence Lytton discloses 9.6% beneficial ownership - Stock Titan
MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 - The Manila Times
Mdxhealth schedules live Q&A on second-quarter results Aug. 13 - Stock Titan
MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MDXH|MDxHealth SA|Price:0.410|Chg%:-0.012 - TradingKey
MDxHealth SA (MDXH) Cash Flow - TradingKey
MDxHealth SA Revenue Breakdown – NASDAQ:MDXH - TradingView
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency - The Manila Times
MDXH Faces Nasdaq Compliance Challenge with Market Value Below $35M - GuruFocus
MDxHealth Faces New Nasdaq Warning Over Market Value Shortfall - TipRanks
Mdxhealth (NASDAQ: MDXH) warned on US$35M Nasdaq market value rule - Stock Titan
mdxhealth Receives Nasdaq Notice of Minimum Market Value Deficiency - Quiver Quantitative
Mdxhealth Has Until Jan. 19 to Regain Compliance or May Face Delisting - Stock Titan
MDxHealth SA (MDXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MDxHealth SA (MDXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MDxHealth SA (MDXH) Institutional Confidence - TradingKey
MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDxHealth SA (MDXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MDXH|MDxHealth SA|Price:0.421|Chg%:+0.011 - TradingKey
MDXH|MDxHealth SA|Price:0.422|Chg%:-0.015 - TradingKey
Brendan Oconnell Net Worth (2026) - GuruFocus
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):